Literature DB >> 25054813

Cancer stem cells: moving past the controversy.

Justin D Lathia1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 25054813      PMCID： PMC6136067          DOI： 10.2217/cns.13.42

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


× No keyword cloud information.
  19 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  Acidic stress promotes a glioma stem cell phenotype.

Authors:  A B Hjelmeland; Q Wu; J M Heddleston; G S Choudhary; J MacSwords; J D Lathia; R McLendon; D Lindner; A Sloan; J N Rich
Journal:  Cell Death Differ       Date:  2010-12-03       Impact factor: 15.828

Review 5.  Cancer stem cells: current status and evolving complexities.

Authors:  Jane E Visvader; Geoffrey J Lindeman
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

6.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

7.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

8.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

9.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

10.  Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

Authors:  William A Flavahan; Qiulian Wu; Masahiro Hitomi; Nasiha Rahim; Youngmi Kim; Andrew E Sloan; Robert J Weil; Ichiro Nakano; Jann N Sarkaria; Brett W Stringer; Bryan W Day; Meizhang Li; Justin D Lathia; Jeremy N Rich; Anita B Hjelmeland
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884
View more
  8 in total

Review 1.  Cancer stem cells in breast and prostate: Fact or fiction?

Authors:  Rocío G Sampayo; Mina J Bissell
Journal:  Adv Cancer Res       Date:  2019-06-13       Impact factor: 6.242

Review 2.  Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.

Authors:  Tamara J Abou-Antoun; James S Hale; Justin D Lathia; Stephen M Dombrowski
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 3.  Mesenchymal Epithelial Transition Factor Signaling in Pediatric Nervous System Tumors: Implications for Malignancy and Cancer Stem Cell Enrichment.

Authors:  Amanda Rose Khater; Tamara Abou-Antoun
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 4.  Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.

Authors:  Koran S Harris; Bethany A Kerr
Journal:  Stem Cells Int       Date:  2017-06-11       Impact factor: 5.443

5.  Network-Based Identification of Altered Stem Cell Pluripotency and Calcium Signaling Pathways in Metastatic Melanoma.

Authors:  Ben-Hur Neves de Oliveira; Carla Dalmaz; Fares Zeidán-Chuliá
Journal:  Med Sci (Basel)       Date:  2018-03-08

Review 6.  Road to stemness in hepatocellular carcinoma.

Authors:  Teresita Nj Flores-Téllez; Saúl Villa-Treviño; Carolina Piña-Vázquez
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

7.  CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance.

Authors:  Koran S Harris; Lihong Shi; Brittni M Foster; Mary E Mobley; Phyllis L Elliott; Conner J Song; Kounosuke Watabe; Carl D Langefeld; Bethany A Kerr
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 8.  Cancer stem cell targeted therapy: progress amid controversies.

Authors:  Tao Wang; Sarah Shigdar; Michael P Gantier; Yingchun Hou; Li Wang; Yong Li; Hadi Al Shamaileh; Wang Yin; Shu-Feng Zhou; Xinhan Zhao; Wei Duan
Journal:  Oncotarget       Date:  2015-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.